• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过亚相成分变化对预先形成的肺表面活性物质表面膜进行可逆和不可逆失活。

Reversible and irreversible inactivation of preformed pulmonary surfactant surface films by changes in subphase constituents.

作者信息

Amirkhanian J D, Taeusch H W

机构信息

Department of Pediatrics, Drew University, Los Angeles, CA.

出版信息

Biochim Biophys Acta. 1993 Jan 10;1165(3):321-6. doi: 10.1016/0005-2760(93)90143-w.

DOI:10.1016/0005-2760(93)90143-w
PMID:8418890
Abstract

Several mechanisms for surfactant inactivation have been reported. In this study, we have measured the reversibility of surfactant inactivation caused by various lipid or protein constituents of plasma or by pH changes. A surfactant of bovine origin was studied in a pulsating surfactometer either when surfactants were premixed with different serum constituents (inactivators) or when inactivators were introduced into subphase fluid surrounding surfactant films formed at an air-liquid interface. Subphase exchanges with sodium bicarbonate or sodium borate raised pH and raised minimal surface tensions either when premixed with surfactant or when introduced with saline subphase beneath a preformed surfactant surface film. The pH effects on surfactant film function were reversible for sodium bicarbonate but not for sodium borate when the subphase with bicarbonate or borate was replaced with saline. Lipids (platelet-activating factor or lysophosphatidylcholine) had non-reversible effects on preformed films. Proteins (fibrinogen or C reactive protein) had reversible effects at low concentrations, but reversibility was less evident at high concentrations. Effects with whole serum were non-reversible at low protein concentrations (0.5 mg/ml). These results add evidence that surfactant inactivation can be caused by multiple mechanisms, both reversible and irreversible.

摘要

已有多种表面活性剂失活机制的报道。在本研究中,我们测定了由血浆的各种脂质或蛋白质成分或pH变化引起的表面活性剂失活的可逆性。在脉动表面张力仪中研究了牛源性表面活性剂,一种情况是将表面活性剂与不同血清成分(失活剂)预混合,另一种情况是将失活剂引入气液界面形成的表面活性剂膜周围的亚相流体中。用碳酸氢钠或硼酸钠进行亚相交换会提高pH值,并提高最小表面张力,无论是在与表面活性剂预混合时,还是在预先形成的表面活性剂表面膜下方用盐水亚相引入时。当用盐水替代含碳酸氢盐或硼酸盐的亚相时,碳酸氢钠对表面活性剂膜功能的pH效应是可逆的,而硼酸钠则不可逆。脂质(血小板活化因子或溶血磷脂酰胆碱)对预先形成的膜有不可逆作用。蛋白质(纤维蛋白原或C反应蛋白)在低浓度时有可逆作用,但在高浓度时可逆性不太明显。在低蛋白浓度(0.5mg/ml)时,全血清的作用是不可逆的。这些结果进一步证明,表面活性剂失活可由多种机制引起,包括可逆和不可逆机制。

相似文献

1
Reversible and irreversible inactivation of preformed pulmonary surfactant surface films by changes in subphase constituents.通过亚相成分变化对预先形成的肺表面活性物质表面膜进行可逆和不可逆失活。
Biochim Biophys Acta. 1993 Jan 10;1165(3):321-6. doi: 10.1016/0005-2760(93)90143-w.
2
Multiple mechanisms of lung surfactant inhibition.肺表面活性物质抑制的多种机制。
Pediatr Res. 1999 Jul;46(1):85-93. doi: 10.1203/00006450-199907000-00015.
3
Full length synthetic surfactant proteins, SP-B and SP-C, reduce surfactant inactivation by serum.
Biochim Biophys Acta. 1993 Jul 1;1168(3):315-20. doi: 10.1016/0005-2760(93)90188-f.
4
Structures of pulmonary surfactant films adsorbed to an air-liquid interface in vitro.体外吸附于气液界面的肺表面活性物质膜的结构
Biochim Biophys Acta. 2005 Dec 30;1720(1-2):59-72. doi: 10.1016/j.bbamem.2005.11.007. Epub 2005 Dec 9.
5
The role of surfactant proteins in DPPC enrichment of surface films.表面活性剂蛋白在表面膜二棕榈酰磷脂酰胆碱富集过程中的作用。
Biophys J. 2000 Dec;79(6):3164-71. doi: 10.1016/S0006-3495(00)76550-7.
6
Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins.表面活性蛋白SP-B可对抗血清蛋白对肺表面活性剂的抑制作用。
Eur J Med Res. 2000 Jul 19;5(7):277-82.
7
Phase transitions in films of lung surfactant at the air-water interface.肺表面活性剂在气-水界面薄膜中的相变
Biophys J. 1998 Jun;74(6):2983-95. doi: 10.1016/S0006-3495(98)78005-1.
8
A biophysical mechanism by which plasma proteins inhibit lung surfactant activity.血浆蛋白抑制肺表面活性物质活性的生物物理机制。
Chem Phys Lipids. 1988 Nov;49(1-2):49-55. doi: 10.1016/0009-3084(88)90063-1.
9
Competitive adsorption: a physical model for lung surfactant inactivation.竞争性吸附:肺表面活性剂失活的物理模型。
Langmuir. 2009 Jul 21;25(14):8131-43. doi: 10.1021/la8039434.
10
Adsorption, compression and stability of surface films from natural, lipid extract and reconstituted pulmonary surfactants.
Biochim Biophys Acta. 1993 Apr 23;1167(3):264-71. doi: 10.1016/0005-2760(93)90228-2.

引用本文的文献

1
The use of negative oxygen ion clusters [O(HO)] and bicarbonate ions [HCO] as the supportive treatment of COVID-19 infections: A possibility.使用负氧离子簇[O(HO)]和碳酸氢根离子[HCO]作为支持治疗 COVID-19 感染的可能性。
Med Hypotheses. 2021 Sep;154:110658. doi: 10.1016/j.mehy.2021.110658. Epub 2021 Aug 5.
2
Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental.血清抑制吸附导致肺表面活性物质失活及亲水性聚合物的逆转:实验研究
Biophys J. 2005 Sep;89(3):1769-79. doi: 10.1529/biophysj.105.062620. Epub 2005 May 27.
3
Phase transitions in films of lung surfactant at the air-water interface.
肺表面活性剂在气-水界面薄膜中的相变
Biophys J. 1998 Jun;74(6):2983-95. doi: 10.1016/S0006-3495(98)78005-1.
4
Effects of cationic liposome-DNA complexes on pulmonary surfactant function in vitro and in vivo.
Lipids. 1997 Mar;32(3):247-53. doi: 10.1007/s11745-997-0031-2.
5
Antigen-induced generation of lyso-phospholipids in human airways.抗原诱导的人类气道中溶血磷脂的生成。
J Exp Med. 1996 May 1;183(5):2235-45. doi: 10.1084/jem.183.5.2235.
6
Inhibition of pulmonary surfactant biophysical activity by cationic polyamino acids.阳离子聚氨基酸对肺表面活性剂生物物理活性的抑制作用。
Pharm Res. 1995 Nov;12(11):1658-63. doi: 10.1023/a:1016297118227.
7
Reduction of the surface-tension-lowering ability of surfactant after exposure to hypochlorous acid.暴露于次氯酸后表面活性剂降低表面张力能力的降低。
Biochem J. 1993 Oct 1;295 ( Pt 1)(Pt 1):19-22. doi: 10.1042/bj2950019.
8
The influence of pH on surface properties of lung surfactants.pH对肺表面活性剂表面性质的影响。
Lung. 1995;173(4):243-54. doi: 10.1007/BF00181876.